-
Hospitals to ration IV fluids after shortage ends
Despite an end to the recent IV fluid shortage being in sight, hospital administrators may continue to adjust standard practices, KFF Health News reported Nov. 27. -
Diabetes group recommends against compounded GLP-1s
Clinicians and patients should avoid using compounded GLP-1 products that are not FDA-approved, the American Diabetes Association wrote in a guidance statement published Dec. 2 in Diabetes Care. -
An opportunity for a refreshed pharmacy chain model
The shrinking presence of brick-and-mortar pharmacies is opening doors for new chain models to emerge, NJBiz reported Dec. 2. -
Texas system acquires pharmacy
The Comanche County Medical Center health system has bought a pharmacy in Goldthwaite, Texas. -
Sanofi adds new $600M manufacturing plant
Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27. -
Medicare prescription drug pricing variance: 5 things to know
Medicare beneficiaries are facing wide price discrepancies for prescription drugs, with the same medication costing vastly different amounts, depending on the plan and location, The Wall Street Journal reported Nov. 26. -
6 GLP-1 study findings to know
GLP-1 medications like Mounjaro and Saxenda might benefit stroke survivors and reduce some patients' healthcare costs, according to researchers. -
Controversial Alzheimer's drug trial halted
Cassava Sciences announced that the phase 3 trial of its Alzheimer's drug, simufilam, did not meet its primary endpoints. -
Healthcare leaders urge Congress to recognize pharmacists as providers
In a Nov. 25 letter sent to congressional leaders, the Healthcare Leadership Council pressed legislators to restore pandemic-era pharmacist scopes of practice. -
Asthma drug linked to severe mental health side effects: FDA
A new study on asthma medication Singulair has raised concerns about its potential mental health side effects, USA Today reported Nov. 24. -
Trump tariffs could drive up generic drug costs: 5 takeaways
President-elect Donald Trump's proposed tariffs on foreign imports could lead to higher costs for generic drugs, policy experts say. -
Cleveland Clinic London pharmacy reaches milestone
Cleveland Clinic London Hospital has launched the first phase of its central intravenous additive service unit for non-hazardous sterile compounds. -
NYC Health + Hospitals to upgrade medication management technology
NYC Hospitals + Health is rolling out a multimillion dollar upgrade to its medication management systems, aimed at improving efficiency and patient safety access across the network. -
GLP-2s, explained
GLP-1s and GLP-2s, or glucagon-like peptides, are both secreted from gut endocrine cells and promote nutrient absorption. As medications, they differ vastly. -
Anxiety medication recalled for 'life-threatening' labeling error
Endo USA has expanded its voluntary recall of clonazepam orally disintegrating tablets due to a mislabeling issue that could lead to patients accidentally ingesting the wrong dosage. -
Sanofi joins effort to alter 340B program
Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22. -
Florida drug importation plan stalls nearly a year after approval: 5 notes
Almost a year after receiving FDA approval, Florida's plan to import lower-cost prescription drugs from Canada remains mired in delays, KFF Health News reported Nov. 21. -
RFK Jr.'s comments on Ozempic: What to know
Robert F. Kennedy Jr., who was recently nominated to lead HHS during Donald Trump's second presidency, has cast doubt on Ozempic's potential health effects. -
New York cracks down on PBM drug prices
New York state has introduced new regulations aimed at curbing the practices of pharmacy benefit managers, including divisions of CVS Health, Cigna Group and UnitedHealth Group, Bloomberg reported Nov. 20. -
ASHP taps chief information officer
Anil Ravandur has been named the new chief information officer and vice president of the office of information technology at the American Society of Health-System Pharmacists.
Page 6 of 50